The responsibility for oral healthcare doesn’t rest solely with patients or their dentists – it’s a collaborative effort supported by an entire industry dedicated to innovation. Behind every healthy smile, there is a network of professionals working tirelessly to develop state-of-the-art technology to preserve and enhance oral health.
Dento USA, the North American subsidiary of Dentognostics – a German pioneer in salivary screening – plays a leading role in this rapidly advancing field. Dentognostics was founded by Dirk-Rolf Gieselmann, who now serves as Chairman of the Dentognostics Group. With strong backing from PDS Health, the Dental Innovation Alliance and Dental365, Dentognostics has made a bold entry into the American market, with Dento USA at the forefront of this expansion.
In early 2024, the company appointed Andrew Robinson as President and CEO of Dento USA. With an impressive track record, including his tenure as North America Senior Vice President at Dentsply Sirona, he brings the expertise needed to drive Dento USA’s growth.
“Our mission is to empower dental professionals with cutting-edge screening tools that transform patient care,” Robinson tells The CEO Magazine. “We aim to enhance clinical decision-making, improve patient outcomes and increase treatment acceptance by delivering real-time, data-driven insights through our innovative salivary screening tool.”
Dento USA’s commitment to advancing the dental industry is evident in its mission to equip professionals with tools that enable precise, proactive and patient-focused care. Through leadership and innovation, the company is shaping the future of oral health.
Saliva screening benefits
That innovative salivary screening tool is the OralFitnessCheck®. It provides immediate, actionable insights into a patient’s oral health and provides results, chairside, in just minutes. This allows dental professionals to optimize their time while offering patients clear, decisive information about their oral health status.
For Robinson, this is one of the key advantages of saliva screening: it enables a more proactive and personalized approach to care compared to traditional methods.
“Unlike blood or urine testing, saliva testing is entirely non-invasive and painless, making it far more comfortable for patients,” Robinson explains. “Samples can be collected quickly and easily, often without specialized personnel or equipment.
“This simplicity not only enhances patient comfort but also reduces costs, making it an attractive option for both patients and healthcare providers. Best of all, results are delivered rapidly.”
“Our mission is to empower dental professionals with advanced screening tools that transform patient care.”
More importantly, saliva can reveal information that other methods often miss. It contains biomarkers, such as aMMP-8, which is critical for detecting the early breakdown of tissue in the mouth. Armed with this real-time data, clinicians can prevent and treat oral diseases more effectively and at an earlier stage.
“As our understanding of the oral-systemic health connection grows, saliva screening is becoming essential to a holistic approach to patient care,” Robinson says. “Incorporating saliva testing into routine exams allows dental professionals to address oral health while also considering its broader implications for overall health.”
By providing timely insights and bridging the gap between oral and systemic care, the OralFitnessCheck is shaping the future of proactive dentistry.
Dental partners
The transformative potential of Dento USA’s technology has made it a sought-after partner in the dental industry in the United States. The company’s products are already being utilized by leaders like PDS Health and Dental365, with both organizations seeing great success. Such collaborations are pivotal not only for Dento USA’s growth but also for the advancement of the dental industry as a whole, says Robinson.
“The partnership between Dento USA and PDS Health is strategically aligned with our shared mission: advancing oral healthcare and improving patient outcomes through innovative technology,” he notes.
By integrating Dento USA’s advanced saliva screening tools, Robinson believes PDS Health can elevate its patient offerings.
“This technology allows them to identify patients with active periodontal tissue breakdown before clinical symptoms appear,” he explains. “It’s a proactive approach that improves clinical outcomes and aligns with the industry’s shift from reactive care to anticipatory healthcare.”
“As our understanding of the oral-systemic health connection grows, saliva screening is becoming essential to a holistic approach to patient care.”
This proactive model also motivates patients to take ownership of their oral health.
“Our accessible and informative results give patients clear insights into their oral fitness, helping them understand the importance of good dental hygiene and empowering them to actively participate in their health journey,” he says.
The company’s OralFitnessCheck seamlessly integrates into existing dental workflows, making it an indispensable tool for comprehensive dental care.
“With OralFitnessCheck, we’re enhancing practice efficiency, empowering dental professionals to deliver proactive, high-quality care and engaging patients with actionable insights to improve their oral health,” he adds.
As oral healthcare continues to advance, Robinson emphasizes that even Dento USA’s cutting-edge innovations are just the beginning. He believes future collaborations, like the partnership with PDS Health, will drive the industry forward.
“We are committed to supporting our partners, like PDS Health, in successfully deploying our tests and leading the way in prognostic, proactive and personalized patient care,” he concludes.
